Genome-Wide Profiles of Extra-cranial Malignant Rhabdoid Tumors Reveal Heterogeneity and Dysregulated Developmental Pathways-Reference-Cited by-同舟云学术

Genome-Wide Profiles of Extra-cranial Malignant Rhabdoid Tumors Reveal Heterogeneity and Dysregulated Developmental Pathways

Published:2016-03 Issue:3 Volume:29 Page:394-406
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Chun Hye-Jung E.,Lim Emilia L.,Heravi-Moussavi Alireza,Saberi Saeed,Mungall Karen L.,Bilenky Mikhail,Carles Annaick,Tse Kane,Shlafman Inna,Zhu Kelsey,Qian Jenny Q.,Palmquist Diana L.,He An,Long William,Goya Rodrigo,Ng Michelle,LeBlanc Veronique G.,Pleasance Erin,Thiessen Nina,Wong Tina,Chuah Eric,Zhao Yong-Jun,Schein Jacquie E.,Gerhard Daniela S.,Taylor Michael D.,Mungall Andrew J.,Moore Richard A.,Ma Yussanne,Jones Steven J.M.,Perlman Elizabeth J.,Hirst Martin,Marra Marco A.

Funder

National Cancer Institute

NIH

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference89 articles.

1. Ordered recruitment of chromatin modifying and general transcription factors to the IFN-beta promoter;Agalioti;Cell,2000

2. Signatures of mutational processes in human cancer;Alexandrov;Nature,2013

3. Long-term survival and transmission of INI1-mutation via nonpenetrant males in a family with rhabdoid tumour predisposition syndrome;Ammerlaan;Br. J. Cancer,2008

4. Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB;Betz;Oncogene,2002

5. The role of INI1 and the SWI/SNF complex in the development of rhabdoid tumors: meeting summary from the workshop on childhood atypical teratoid/rhabdoid tumors;Biegel;Cancer Res.,2002

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumors;Neuro-Oncology;2024-07-09

2. Targeting dependency on a paralog pair of CBP/p300 against de-repression of KREMEN2 in SMARCB1-deficient cancers;Nature Communications;2024-06-05

3. Synergistic Antitumor Activity of Talazoparib and Temozolomide in Malignant Rhabdoid Tumors;Cancers;2024-05-28

4. Synovial Sarcoma Chromatin Dynamics Reveal a Continuum in SS18:SSX Reprograming;2024-05-17

5. Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomas;2024-05-06